Brain vascular dysfunction in cerebral malaria

脑型疟疾的脑血管功能障碍

基本信息

  • 批准号:
    9017256
  • 负责人:
  • 金额:
    $ 52.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-15 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): CM is a serious complication of Plasmodium falciparum infection, and has a profoundly devastating effect especially on children, non-immune travelers and military personnel. Clinically, CM can result in several neurological problems, which include seizures, reversible coma and is associated with a high mortality of up to 30%, with the highest rate in children. Acute neurological symptoms include impaired consciousness, coma, delirium, seizures, and increased intracranial hypertension. The hallmark of CM pathology is the intra-vascular sequestration of parasitized red blood cells (PRBC) inside high endothelial venules throughout the brain. PRBC bind to the blood brain barrier (BBB) endothelium in both WM and gray matter (GM) but do not invade into the brain. Interestingly, the PRBC sequestration in blood vessels leads to a distinctly different pathology between WM and GM. Recent postmortem studies reveal a clear hemorrhagic pathology within WM. Our previous data showed highly inflammatory responses associated with GM endothelium. Yet, little is known of the factors that cause these differences of the brain endothelium residing in GM versus WM and how any potential differences could relate to divergent responses in CM. Therefore, we hypothesize that, due to differences in the direct physiological environment of GM and WM (e.g. astrocyte-neuronal versus pericyte-oligodendrocytes), the vessel endothelium in these different brain tissues exhibit differing properties. In combination with a specific var-gene expressing Plasmodium binding pattern, these different endothelial properties result in diverging CM pathologies. Here, we propose to study the underlying WM versus GM endothelial differences and responses to PRBC by using in vitro models of human BBB, and compare these differences to in situ human brain samples and vascular responses in an in vivo experimental CM model. This application is response to RFA-HL-15-023 Vascular Dysfunction in the Pathogenesis of Severe Malaria (R01). These studies will provide an improved understanding of the BBB and could provide new understandings of the molecular mechanisms of the brain vessels differentiation in WM versus GM that may also be implicated in other neurological diseases.
 描述(由申请人提供):CM是恶性疟原虫感染的一种严重并发症,特别是对儿童、非免疫旅行者和军事人员具有深刻的破坏性影响。临床上,CM可导致几种神经系统问题,包括癫痫发作、可逆性昏迷,并且与高达30%的死亡率相关,其中儿童的死亡率最高。急性神经系统症状包括意识受损、昏迷、谵妄、癫痫发作和颅内高压增加。 CM病理学的标志是寄生红细胞(PRBC)在整个脑的高内皮小静脉内的血管内隔离。PRBC与WM和灰质(GM)中的血脑屏障(BBB)内皮结合,但不侵入脑内。有趣的是,PRBC在血管中的隔离导致WM和GM之间明显不同的病理学。 最近的尸检研究揭示了一个明确的出血病理WM。我们以前的数据显示与GM内皮相关的高度炎症反应。然而,很少有人知道的因素,导致这些差异的脑内皮细胞居住在GM与WM和任何潜在的差异可能涉及到不同的反应,在CM。因此,我们假设,由于GM和WM的直接生理环境的差异(例如星形胶质细胞-神经元与周细胞-少突胶质细胞),这些不同脑组织中的血管内皮表现出不同的特性。与一种特殊的var基因结合 表达疟原虫结合模式,这些不同的内皮特性导致不同的CM病理。 在这里,我们建议研究潜在的WM与GM内皮细胞的差异和PRBC的反应,通过使用体外模型的人血脑屏障,并比较这些差异原位人脑样本和血管反应在体内实验CM模型。 本申请是对RFA-HL-15-023重度疟疾发病机制中的血管功能障碍(R 01)的回应。这些研究将提供对BBB的更好理解,并可以提供对WM与GM脑血管分化分子机制的新理解,这也可能与其他神经系统疾病有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARCELO JACOBS-LORENA其他文献

MARCELO JACOBS-LORENA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARCELO JACOBS-LORENA', 18)}}的其他基金

Molecular mechanisms of Plasmodium fertilization
疟原虫受精的分子机制
  • 批准号:
    9212860
  • 财政年份:
    2016
  • 资助金额:
    $ 52.54万
  • 项目类别:
Molecular mechanisms of Plasmodium fertilization
疟原虫受精的分子机制
  • 批准号:
    10064068
  • 财政年份:
    2016
  • 资助金额:
    $ 52.54万
  • 项目类别:
Characterization of Plasmodium GAPDH as a candidate for development of a malaria pre-erythrocytic vaccine
疟原虫 GAPDH 作为开发疟疾前红细胞疫苗候选物的表征
  • 批准号:
    9228326
  • 财政年份:
    2016
  • 资助金额:
    $ 52.54万
  • 项目类别:
Brain vascular dysfunction in cerebral malaria
脑型疟疾的脑血管功能障碍
  • 批准号:
    9281895
  • 财政年份:
    2015
  • 资助金额:
    $ 52.54万
  • 项目类别:
Brain vascular dysfunction in cerebral malaria
脑型疟疾的脑血管功能障碍
  • 批准号:
    9529367
  • 财政年份:
    2015
  • 资助金额:
    $ 52.54万
  • 项目类别:
2013 TROPICAL INFECTIOUS DISEASES: FROM BENCH TO FIELD GORDON RESEARCH CONFERENCE
2013 热带传染病:从实验室到现场戈登研究会议
  • 批准号:
    8452997
  • 财政年份:
    2013
  • 资助金额:
    $ 52.54万
  • 项目类别:
2011 Tropical Infectious Diseases Gordon Research Conference
2011年热带传染病戈登研究会议
  • 批准号:
    8119215
  • 财政年份:
    2011
  • 资助金额:
    $ 52.54万
  • 项目类别:
Reducing malaria transmission with engineered bacteria
利用工程细菌减少疟疾传播
  • 批准号:
    8137946
  • 财政年份:
    2010
  • 资助金额:
    $ 52.54万
  • 项目类别:
Reducing malaria transmission with engineered bacteria
利用工程细菌减少疟疾传播
  • 批准号:
    7869162
  • 财政年份:
    2010
  • 资助金额:
    $ 52.54万
  • 项目类别:
Vector biology-Using a mosquito pathogen as a delivery system for anti-malarial a
媒介生物学-使用蚊子病原体作为抗疟疾药物的传递系统
  • 批准号:
    7660719
  • 财政年份:
    2009
  • 资助金额:
    $ 52.54万
  • 项目类别:

相似海外基金

I-Corps: Translation Potential of Peptidic Ensembles as Novel Bio-adhesives
I-Corps:肽整体作为新型生物粘合剂的转化潜力
  • 批准号:
    2409620
  • 财政年份:
    2024
  • 资助金额:
    $ 52.54万
  • 项目类别:
    Standard Grant
Architectural design of active adhesives
活性粘合剂的结构设计
  • 批准号:
    2403716
  • 财政年份:
    2024
  • 资助金额:
    $ 52.54万
  • 项目类别:
    Standard Grant
Design of non-swellable adhesives for brain surgery using cyclodextrin inclusion polymer
使用环糊精包合物聚合物脑外科不可溶胀粘合剂的设计
  • 批准号:
    23H01718
  • 财政年份:
    2023
  • 资助金额:
    $ 52.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Meta-material adhesives for improved performance and functionalisation of bondlines
超材料粘合剂可提高粘合层的性能和功能化
  • 批准号:
    EP/W019450/1
  • 财政年份:
    2023
  • 资助金额:
    $ 52.54万
  • 项目类别:
    Fellowship
Light-propelled dental adhesives with enhanced bonding capability
具有增强粘合能力的光驱动牙科粘合剂
  • 批准号:
    10741660
  • 财政年份:
    2023
  • 资助金额:
    $ 52.54万
  • 项目类别:
DMREF: Accelerating the Design of Adhesives with Nanoscale Control of Thermomechanical Properties
DMREF:通过热机械性能的纳米级控制加速粘合剂的设计
  • 批准号:
    2323317
  • 财政年份:
    2023
  • 资助金额:
    $ 52.54万
  • 项目类别:
    Continuing Grant
Mag-Cure: A novel method for magnetically induced bonding and de-bonding of thermoset adhesives in the Automotive Industry
Mag-Cure:汽车行业中热固性粘合剂磁感应粘合和脱粘的新方法
  • 批准号:
    10062336
  • 财政年份:
    2023
  • 资助金额:
    $ 52.54万
  • 项目类别:
    Collaborative R&D
Biodegradable, Biocompatible Pressure Sensitive Adhesives
可生物降解、生物相容性压敏粘合剂
  • 批准号:
    10677869
  • 财政年份:
    2022
  • 资助金额:
    $ 52.54万
  • 项目类别:
Poly(glycerol carbonate) pressure sensitive adhesives for the in vivo closure of alveolar pleural fistulae
用于体内闭合肺泡胸膜瘘的聚(甘油碳酸酯)压敏粘合剂
  • 批准号:
    10746743
  • 财政年份:
    2022
  • 资助金额:
    $ 52.54万
  • 项目类别:
Enhanced bio-production of difficult to make peptide ingredients for specialty adhesives and personal care
增强用于特种粘合剂和个人护理品的难以制造的肽成分的生物生产
  • 批准号:
    10021363
  • 财政年份:
    2022
  • 资助金额:
    $ 52.54万
  • 项目类别:
    Investment Accelerator
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了